Targeting osteosarcoma vasculature with peptide obtained by phage display

Mingqiang Guan; Jian Wang; Lanbo Yang; Zandong Zhao; Kun Lu; Liang Zhao; Jun Xiao; Zhihan Li; Zhanjun Shi

doi:10.5114/wo.2014.41384

eISSN: 1897-4309
ISSN: 1428-2526

Contemporary Oncology/Współczesna Onkologia

Current issue Archive Manuscripts accepted About the journal Supplements Addendum Special Issues Editorial board Reviewers Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures

Editorial System

Submit your Manuscript

Editorial Policies

Sarajevo Declaration on Integrity and Visibility of Scholarly Publications

3/2014
vol. 18

Send email

Copy url:

abstract:

Original paper

Targeting osteosarcoma vasculature with peptide obtained by phage display

Mingqiang Guan

,

Jian Wang

,

Lanbo Yang

,

Zandong Zhao

,

Kun Lu

,

Liang Zhao

,

Jun Xiao

,

Zhihan Li

,

Zhanjun Shi

Contemp Oncol (Pozn) 2014; 18 (3): 165–170

DOI: https://doi.org/10.5114/wo.2014.41384

Online publish date: 2014/04/25

View full text Get citation

PlumX metrics:

Aim of the study: Tumour endothelial cells have been proven to have molecular markers distinct from normal endothelial cells. These specific molecular markers allow for targeting of the tumour vasculature with specific pharmacological vehicles to direct diagnostic or therapeutic modalities at the endothelial cells. By performing a phage display-based screening, this study aimed to identify a certain short peptide that could specifically bind to osteosarcoma vasculature.

Material and methods: We performed in vivo screening in the murine models of osteosarcoma with annular Ph.D.-C7C library in the present study. To explore the in vivo binding specificity of the retrieved peptide, we conjugated the peptide with fluorescein isothiocyanate (FITC) and injected it intravenously into osteosarcoma-bearing BALB-c mice.

Results: CTKPDKGYC was the dominant sequence isolated from in vivo screening and was named as NF-1. Fluorescence staining found that FITC-NF-1 peptide could be specifically homed to osteosarcoma vasculature while being almost undetectable in the heart, brain, lung and liver. Simultaneously, a small amount of fluorescence could also be detected in the renal glomerulus and renal tubule but not in renal vascular endothelium, indicating that FITC-NF-1 peptide might be excreted mainly through the renal-urinary route.

Conclusions: Our data suggest that, with high binding specificity to osteosarcoma vasculature, peptide NF-1 may have potential value in early diagnosis or targeted therapy for osteosarcoma.

keywords:

Targeting osteosarcoma vasculature with peptide obtained by phage display

Mingqiang Guan , Jian Wang , Lanbo Yang , Zandong Zhao , Kun Lu , Liang Zhao , Jun Xiao , Zhihan Li , Zhanjun Shi

osteosarcoma (OS), phage display, peptide, angiogenesis

Mingqiang Guan

,

Jian Wang

,

Lanbo Yang

,

Zandong Zhao

,

Kun Lu

,

Liang Zhao

,

Jun Xiao

,

Zhihan Li

,

Zhanjun Shi